Here we describe a protocol to produce a recombinant adeno-associated viral vector (rAAV)-based system to deliver the CRISPR-Cas9 complex into porcine skeletal muscle and myocardial cells. We initially describe the genomic composition of the rAAV-CRISPR vectors used in our lab. Furthermore, we give a step-by-step instruction into the production of recombinant viral vectors with high yields and purity. Lastly we describe the minimally invasive injection regimes to target the myocardium in a pig.
Keywords: CRISPR; Cas9; Duchenne muscular dystrophy; Gene editing; Gene vector; rAAV.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.